Imaging Recommendations for Diagnosis, Staging, and Management of Hematological Malignancies
Abstract: The NIC defines hematological cancers as those that begin in blood forming tissues such as bone marrow or cells of the immune system and these broadly include three groups: leukemias, lymphomas, and myelomas. The role of imaging is also fundamentally different between the three main groups of hematological malignancies. While imaging is the main tool for staging as well as treatment response assessment in lymphoma, it represents one of several key criteria for the diagnosis and follow-up of myeloma; whereas in leukemia, imaging has a role to play in the detection and management of treatment-related complications which is a crucial part of post-transplant treatment.
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Imaging Recommendations for Diagnosis, Staging, and Management of Hematological Malignancies ; volume:44 ; number:03 ; year:2023 ; pages:302-307
Indian journal of medical & paediatric oncology ; 44, Heft 03 (2023), 302-307
- Contributor
-
Guha, Amrita
- DOI
-
10.1055/s-0042-1760327
- URN
-
urn:nbn:de:101:1-2023062911411029330337
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Guha, Amrita
Other Objects (12)
Imaging Recommendations for Diagnosis, Staging, and Management of Peritoneal Malignancies
Imaging Recommendations for Diagnosis, Staging, and Management of Hereditary Malignancies
Imaging Recommendations for Diagnosis, Staging, and Management of Bladder and Urethral Malignancies
Imaging Recommendations for Diagnosis, Staging, and Management of Small Bowel and Colorectal Malignancies
Deubiquitinases in hematological malignancies
Rac GTPases in hematological malignancies
Checkpoint inhibitors in hematological malignancies
Hematological Malignancies and Arterial Thromboembolism
Mitochondrial transfer in hematological malignancies
Role of CD47 in Hematological Malignancies
Cellular immunotherapy for refractory hematological malignancies
Targeting immune checkpoints in hematological malignancies
Imaging Recommendations for Diagnosis, Staging, and Management of Peritoneal Malignancies
Imaging Recommendations for Diagnosis, Staging, and Management of Hereditary Malignancies
Imaging Recommendations for Diagnosis, Staging, and Management of Bladder and Urethral Malignancies
Imaging Recommendations for Diagnosis, Staging, and Management of Small Bowel and Colorectal Malignancies
Deubiquitinases in hematological malignancies
Rac GTPases in hematological malignancies
Checkpoint inhibitors in hematological malignancies
Hematological Malignancies and Arterial Thromboembolism
Mitochondrial transfer in hematological malignancies
Role of CD47 in Hematological Malignancies
Cellular immunotherapy for refractory hematological malignancies
Targeting immune checkpoints in hematological malignancies
Imaging Recommendations for Diagnosis, Staging, and Management of Peritoneal Malignancies
Imaging Recommendations for Diagnosis, Staging, and Management of Hereditary Malignancies
Imaging Recommendations for Diagnosis, Staging, and Management of Bladder and Urethral Malignancies
Imaging Recommendations for Diagnosis, Staging, and Management of Small Bowel and Colorectal Malignancies
Deubiquitinases in hematological malignancies
Rac GTPases in hematological malignancies
Checkpoint inhibitors in hematological malignancies
Hematological Malignancies and Arterial Thromboembolism
Mitochondrial transfer in hematological malignancies
Role of CD47 in Hematological Malignancies
Cellular immunotherapy for refractory hematological malignancies